Fund Holdings — Aisling Capital Management LP

Total Portfolio Value:
$299.32M
Total Bought:
$1.35M
Total Sold:
$147.42M
Net Transaction:
-$146.07M
Notable People:
Andrew Newman Schiff, Steven Arnote Elms, Aisling Capital Partners Iv Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma, Inc.(BBIO)4,589,6113,089,611-1,500,000$341.83M$203.30M67.92%-$138.54M
Syndax Pharmaceuticals, Inc.(SNDX)1,316,8061,316,8060$28.79M$24.76M8.27%-$4.03M
COMPASS Pathways plcADS(CMPS)1,432,3361,732,336+300,000$20.27M$21.55M7.20%+$1.28M
Monte Rosa Therapeutics Inc1,555,6641,555,6640$37.65M$18.56M6.20%-$19.09M
Bicara Therapeutics Inc568,919548,919-20,000$16.89M$10.22M3.41%-$6.68M
UroGen Pharma Ltd.(URGN)108,000108,0000$3.97M$4.39M1.47%+$413.6K
Bridgebio Oncology Therapeut1,018,0181,018,0180$7.76M$4.14M1.38%-$3.62M
Eupraxia Pharmaceuticals Inc325,000325,0000$2.15M$2.96M0.99%+$809.3K
Biomea Fusion Inc2,048,7572,048,7570$3.01M$2.74M0.92%-$268.8K
Aclaris Therapeutics Inc434,455434,4550$2.30M$2.29M0.76%-$13.0K
Scholar Rock Holding Corporation(SRRK)77,03142,031-35,000$4.24M$2.03M0.68%-$2.21M
Vtv Therapeutics IncCL A50,00058,775+8,775$1.88M$1.81M0.61%-$69.9K
Marker Therapeutics Inc325,370325,3700$478.3K$348.1K0.12%-$130.1K
Onkure Therapeutics IncCL A88,60788,6070$404.0K$241.5K0.08%-$162.6K
Page 1 of 1
Aisling Capital Management LP — 13F Holdings — Q3 2026 | TickerTrail